Jiangsu Tianyin Pharmaceutical

Tianyin Pharmaceutical is a China-based pharmaceutical company specializing in the development, manufacturing, and commercialization of modernized Traditional Chinese Medicine (mTCM) and generic small molecule drugs. The company operates primarily through its subsidiary, Chengdu Tianyin Pharmaceutical, and maintains a diverse portfolio of over 50 products approved by the China Food and Drug Administration (CFDA). Its core business focuses on therapeutic areas such as internal medicine, gynecology, and pediatrics, with flagship products targeting chronic hepatitis and cardiovascular conditions. Tianyin Pharmaceutical integrates traditional herbal medicine with modern pharmacological standards to serve the domestic Chinese healthcare market.